Expert dermatologists review the presentation of psoriasis in patients with skin of color and the challenges physicians face in diagnosing psoriasis in this patient population.
Optimizing Treatment of Psoriasis in Patients with Skin of Color
Drs Stein Gold, Shahriari and Desai highlight social and cultural stigma of psoriasis in patients with skin of color and its impact on patient’s quality of life.
2 expert dermatologists provide tips for communicating, in a culturally sensitive manner, with patients with skin of color.
Dr Linda Stein Gold and Dr Mona Shahriari discuss post-inflammatory dyspigmentation in patients with skin of color and its impact on patient’s quality of life.
Dr Stein Gold and Dr Shahriari review steroidal and non-steroidal topical treatments that are available for use in psoriasis.
Drs Desai, Shahriari, and Stein Gold examine use and place of traditional systemic treatments in psoriasis.
Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai discuss VISIBLE trial, a randomized clinical trial specifically designed to examine treatment outcomes with guselkumab in patients with skin of color.
Dermatology experts highlight VISIBLE trial results when using guselkumab in patients with skin of color.
Drs Stein Gold and Desai share their thoughts on the early use of psoriasis systemic treatments in patients with skin of color.
Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai share how they utilize biologics data from skin of color cohorts in their practice.
Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai share advice for improving psoriasis care for patients with skin of color.
Advertisement
Advertisement
Trending on HCPLive
1
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD
2
Counseling Patients On Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS
3
New Nonsteroidal Options Are Reshaping Pediatric Atopic Dermatitis Care
4
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape?
5